Buchumschlag

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study

Conversion from calcineurin inhibitor (CNI) therapy to everolimus within 6 months after kidney transplantation improves long-term graft function but can increase the risk of mild biopsy-proven acute cellular rejection (BPAR). We performed a post-hoc analysis of histological data from a randomized tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Eisenberger, Ute (VerfasserIn) , Sommerer, Claudia (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 28 June 2018
In: BMC nephrology
Year: 2018, Jahrgang: 19, Pages: 1-8
ISSN:1471-2369
DOI:10.1186/s12882-018-0950-1
Online-Zugang:Verlag, Volltext: https://doi.org/10.1186/s12882-018-0950-1
Verlag, Volltext: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-018-0950-1
Volltext
Verfasserangaben:Ute Eisenberger, Klemens Budde, Frank Lehner, Claudia Sommerer, Petra Reinke, Oliver Witzke, Rudolf P. Wüthrich, Rolf Stahl, Katharina Heller, Barbara Suwelack, Anja Mühlfeld, Ingeborg A. Hauser, Silvio Nadalin, Martina Porstner, Wolfgang Arns
Beschreibung
Zusammenfassung:Conversion from calcineurin inhibitor (CNI) therapy to everolimus within 6 months after kidney transplantation improves long-term graft function but can increase the risk of mild biopsy-proven acute cellular rejection (BPAR). We performed a post-hoc analysis of histological data from a randomized trial in order to further analyze histologic information obtained from indication and protocol biopsies up to 5 years after transplantation.
Beschreibung:Gesehen am 13.08.2019
Beschreibung:Online Resource
ISSN:1471-2369
DOI:10.1186/s12882-018-0950-1

Ähnliche Einträge